Retapamulin API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Retapamulin API Manufacturer in India

Retapamulin is a semisynthetic pleuromutilin antibiotic used as a topical antibacterial active pharmaceutical ingredient. It acts by inhibiting bacterial protein synthesis through interaction with the bacterial 50S ribosomal subunit. Retapamulin is the active ingredient in ALTABAX ointment and was developed for the topical treatment of impetigo and certain superficial skin infections. (accessdata.fda.gov)

Retapamulin has the molecular formula C30H47NO4S and FDA-reported molecular weight 517.78 g/mol. It is described as a white to pale-yellow crystalline solid. (accessdata.fda.gov)

Retapamulin API

Retapamulin is a semisynthetic derivative of pleuromutilin. Its development involved fermentation-derived pleuromutilin followed by chemical modification. EMA reports that the commercial active substance is crystalline Form 1, while another polymorphic form has also been identified. Form 1 has a melting point of approximately 126°C, whereas Form 2 melts at approximately 143°C. (ema.europa.eu)

The active substance specification includes identity, HPLC assay, solid-state form by XRPD, HPLC impurities, residual solvents, water, residue on ignition, optical rotation, microbial purity and particle-size distribution. (ema.europa.eu)

Chemical and Pharmaceutical Profile

ParameterValue
Chemical NameAcetic acid, [[(3-exo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]thio]-, (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester
CAS Number224452-66-8
Molecular FormulaC30H47NO4S
Molecular Weight517.78 g/mol
Chemical ClassPleuromutilin antibiotic
Physical FormCrystalline solid
AppearanceWhite to pale-yellow crystalline solid
Commercial Crystal FormForm 1
Melting PointApproximately 126°C for Form 1
Water Solubility0.07 mg/mL at 25°C
Water Solubility CharacterpH-dependent
Therapeutic CategoryTopical antibacterial

FDA confirms the molecular formula and molecular weight, while EMA confirms the polymorphic forms and aqueous solubility. (accessdata.fda.gov; ema.europa.eu)

Pharmaceutical Applications

Retapamulin is used as a topical antibacterial agent for susceptible bacterial skin infections.

Its established pharmaceutical application includes:

  • Impetigo
  • Superficial skin infections associated with susceptible bacteria
  • Topical treatment of traumatic skin lesions with bacterial infection

ALTABAX contains 1% retapamulin in an ointment formulation. (accessdata.fda.gov)

Retapamulin inhibits bacterial protein synthesis through interaction with the 50S ribosomal subunit, providing a mechanism distinct from many conventional topical antibiotics.

Quality and Analytical Testing

Retapamulin API requires control of chemical purity as well as solid-state characteristics. EMA's regulatory assessment confirms the use of:

  • IR identification
  • HPLC assay
  • HPLC related-substance testing
  • XRPD for solid-state form
  • GC for residual solvents
  • Water-content testing
  • Residue on ignition
  • Optical rotation
  • Microbial purity
  • Laser-diffraction particle-size testing

The EMA assessment states that these methods were validated for their intended purposes and that production batches complied with the active-substance specification. (ema.europa.eu)

Retapamulin API Manufacturer in India

Retapamulin API manufacturing requires careful control of its pleuromutilin structure, stereochemistry, crystalline form, related substances, residual solvents and particle-size distribution.

Particular attention should be given to polymorphic form control, because EMA identified two forms and confirmed that Form 1 is the commercially used form. (ema.europa.eu)

Packaging and Storage

Retapamulin should be packaged in suitable pharmaceutical-grade containers that protect the material from moisture, light and contamination.

EMA reports long-term stability studies at 25°C/60% RH for up to 36 months, intermediate studies at 30°C/65% RH, and accelerated studies at 40°C/75% RH. (ema.europa.eu)

Documentation

Typical Retapamulin API documentation may include:

  • Certificate of Analysis (CoA)
  • Certificate of Conformance
  • HPLC assay report
  • Related-substance chromatogram
  • IR identification
  • XRPD solid-state characterization
  • Residual-solvent report
  • Water-content result
  • Residue-on-ignition result
  • Optical-rotation result
  • Particle-size distribution
  • Microbial purity results
  • Stability data
  • SDS
  • Packaging and storage information

Why Choose Retapamulin API Manufacturer in India

Retapamulin is a specialized pleuromutilin antibiotic requiring control of chemical purity, stereochemical integrity, polymorphic form and physical characteristics. A comprehensive API quality program should therefore combine chromatographic, spectroscopic and solid-state analytical methods.

Detailed Specifications

Parameter Specification
Appearance white to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 0.5%
Residue on Ignition NMT 0.5%
Heavy Metals NMT 20 ppm
Individual Impurity NMT 0.5%
Melting Point Approximately 126°C
Get Bulk Quote via WhatsApp